Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
- PMID: 36159792
- PMCID: PMC9500378
- DOI: 10.3389/fimmu.2022.949746
Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
Abstract
Background: Dietary polyphenol treatment of non-alcoholic fatty liver disease (NAFLD) is a novel direction, and the existing clinical studies have little effective evidence for its therapeutic effect, and some studies have inconsistent results. The effectiveness of dietary polyphenols in the treatment of NAFLD is still controversial. The aim of this study was to evaluate the therapeutic efficacy of oral dietary polyphenols in patients with NAFLD.
Methods: The literature (both Chinese and English) published before 30 April 2022 in PubMed, Cochrane, Medline, CNKI, and other databases on the treatment of NAFLD with dietary polyphenols was searched. Manual screening, quality assessment, and data extraction of search results were conducted strictly according to the inclusion and exclusion criteria. RevMan 5.3 software was used to perform the meta-analysis.
Results: The RCTs included in this study involved dietary supplementation with eight polyphenols (curcumin, resveratrol, naringenin, anthocyanin, hesperidin, catechin, silymarin, and genistein) and 2,173 participants. This systematic review and meta-analysis found that 1) curcumin may decrease body mass index (BMI), Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), Triglycerides (TG) total cholesterol (TC), and Homeostasis Model Assessment-Insulin Resistance (HOMA-IR) compared to placebo; and curcumin does not increase the occurrence of adverse events. 2) Although the meta-analysis results of all randomized controlled trials (RCTs) did not reveal significant positive changes, individual RCTs showed meaningful results. 3) Naringenin significantly decreased the percentage of NAFLD grade, TG, TC, and low-density lipoprotein cholesterol (LDL-C) and increased high-density lipoprotein cholesterol (HDL-C) but had no significant effect on AST and ALT, and it is a safe supplementation. 4) Only one team presents a protocol about anthocyanin (from Cornus mas L. fruit extract) in the treatment of NAFLD. 5) Hesperidin may decrease BMI, AST, ALT, TG, TC, HOMA-IR, and so on. 6) Catechin may decrease BMI, HOMA-IR, and TG level, and it was well tolerated by the patients. 7) Silymarin was effective in improving ALT and AST and reducing hepatic fat accumulation and liver stiffness in NAFLD patients.
Conclusion: Based on current evidence, curcumin can reduce BMI, TG, TC, liver enzymes, and insulin resistance; catechin can reduce BMI, insulin resistance, and TG effectively; silymarin can reduce liver enzymes. For resveratrol, naringenin, anthocyanin, hesperidin, and catechin, more RCTs are needed to further evaluate their efficacy and safety.
Keywords: dietary polyphenol; meta-analysis; natural plant active ingredients; non-alcoholic fatty liver disease; systematic review.
Copyright © 2022 Yang, Chen, Zhang, Yuan, Ge, Wang, Xu, Zeng and Ge.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9500378/bin/fimmu-13-949746-g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9500378/bin/fimmu-13-949746-g002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9500378/bin/fimmu-13-949746-g003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9500378/bin/fimmu-13-949746-g004.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9500378/bin/fimmu-13-949746-g005.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9500378/bin/fimmu-13-949746-g006.gif)
![Figure 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9500378/bin/fimmu-13-949746-g007.gif)
Similar articles
-
Effects of different natural products in patients with non-alcoholic fatty liver disease-A network meta-analysis of randomized controlled trials.Phytother Res. 2024 Jun 17. doi: 10.1002/ptr.8182. Online ahead of print. Phytother Res. 2024. PMID: 38886838 Review.
-
The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review.J Transl Med. 2024 Mar 1;22(1):225. doi: 10.1186/s12967-024-05011-2. J Transl Med. 2024. PMID: 38429794 Free PMC article.
-
Effects of curcumin/turmeric supplementation on the liver enzymes, lipid profiles, glycemic index, and anthropometric indices in non-alcoholic fatty liver patients: An umbrella meta-analysis.Phytother Res. 2024 Feb;38(2):539-555. doi: 10.1002/ptr.8051. Epub 2023 Nov 2. Phytother Res. 2024. PMID: 37918958 Review.
-
The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.Complement Ther Med. 2020 Jan;48:102283. doi: 10.1016/j.ctim.2019.102283. Epub 2019 Dec 17. Complement Ther Med. 2020. PMID: 31987259
-
Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.Crit Rev Food Sci Nutr. 2019;59(15):2494-2505. doi: 10.1080/10408398.2018.1458021. Epub 2018 Apr 20. Crit Rev Food Sci Nutr. 2019. PMID: 29584449
Cited by
-
Sylimarin Versus Essential Phospholipids in Metabolic Associated Steatotic Liver Disease (MASLD) - A Prospective Comparative Randomized Trial.Maedica (Bucur). 2024 Mar;19(1):9-16. doi: 10.26574/maedica.2024.19.11.9. Maedica (Bucur). 2024. PMID: 38736928 Free PMC article.
-
The Effects of Cranberry Consumption on Glycemic and Lipid Profiles in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Nutrients. 2024 Mar 9;16(6):782. doi: 10.3390/nu16060782. Nutrients. 2024. PMID: 38542695 Free PMC article.
-
Bioactive Compounds from Pigmented Corn (Zea mays L.) and Their Effect on Health.Biomolecules. 2024 Mar 12;14(3):338. doi: 10.3390/biom14030338. Biomolecules. 2024. PMID: 38540758 Free PMC article. Review.
-
Sirtuins as Players in the Signal Transduction of Citrus Flavonoids.Int J Mol Sci. 2024 Feb 6;25(4):1956. doi: 10.3390/ijms25041956. Int J Mol Sci. 2024. PMID: 38396635 Free PMC article. Review.
-
The Potential Role of Gossypetin in the Treatment of Diabetes Mellitus and Its Associated Complications: A Review.Int J Mol Sci. 2023 Dec 18;24(24):17609. doi: 10.3390/ijms242417609. Int J Mol Sci. 2023. PMID: 38139436 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous